Medicare AdvantageApril 18, 2025
Specialty pharmacy preapproval list update
Effective for dates of service on and after August 1, 2025, the specialty Medicare Part B drug listed in the table below will be included in our preapproval review process.
Federal and state law, state contract language, and CMS guidelines, including definitions and specific contract provisions/exclusions, take precedence over preapproval rules and must be considered first when determining coverage. Claims that do not comply with these new requirements may not be approved.
HCPCS code | Medicare Part B drug |
Q5136 | Jubbonti; Wyost (denosumab‑bbdz) |
Anthem Blue Cross and Blue Shield is the trade name of Anthem Health Plans, Inc. Independent licensee of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.
MULTI-BCBS-CR-077559-25-CPN77132
PUBLICATIONS: May 2025 Provider Newsletter
To view this article online:
Or scan this QR code with your phone